Do immune checkpoint inhibitors need new studies methodology?

Immune checkpoint inhibitors (ICI) have widely reshaped the treatment paradigm of advanced cancer patients. Although multiple studies are currently evaluating these drugs as monotherapies or in combination, the choice of the most accurate statistical methods, endpoints and clinical trial designs to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Autores principales: Ferrara, Roberto, Pilotto, Sara, Caccese, Mario, Grizzi, Giulia, Sperduti, Isabella, Giannarelli, Diana, Milella, Michele, Besse, Benjamin, Tortora, Giampaolo, Bria, Emilio
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994495/
https://ncbi.nlm.nih.gov/pubmed/29951307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.131
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares